These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15016325)

  • 1. Tumor-derived heat shock protein 70-pulsed dendritic cells elicit tumor-specific cytotoxic T lymphocytes (CTLs) and tumor immunity.
    Ueda G; Tamura Y; Hirai I; Kamiguchi K; Ichimiya S; Torigoe T; Hiratsuka H; Sunakawa H; Sato N
    Cancer Sci; 2004 Mar; 95(3):248-53. PubMed ID: 15016325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanoma-reactive class I-restricted cytotoxic T cell clones are stimulated by dendritic cells loaded with synthetic peptides, but fail to respond to dendritic cells pulsed with melanoma-derived heat shock proteins in vitro.
    Fleischer K; Schmidt B; Kastenmüller W; Busch DH; Drexler I; Sutter G; Heike M; Peschel C; Bernhard H
    J Immunol; 2004 Jan; 172(1):162-9. PubMed ID: 14688322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cells pulsed with gp96-peptide complexes derived from human hepatocellular carcinoma (HCC) induce specific cytotoxic T lymphocytes.
    Wang XH; Qin Y; Hu MH; Xie Y
    Cancer Immunol Immunother; 2005 Oct; 54(10):971-80. PubMed ID: 15965645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis.
    Singh-Jasuja H; Toes RE; Spee P; Münz C; Hilf N; Schoenberger SP; Ricciardi-Castagnoli P; Neefjes J; Rammensee HG; Arnold-Schild D; Schild H
    J Exp Med; 2000 Jun; 191(11):1965-74. PubMed ID: 10839811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient cross-presentation by heat shock protein 90-peptide complex-loaded dendritic cells via an endosomal pathway.
    Kurotaki T; Tamura Y; Ueda G; Oura J; Kutomi G; Hirohashi Y; Sahara H; Torigoe T; Hiratsuka H; Sunakawa H; Hirata K; Sato N
    J Immunol; 2007 Aug; 179(3):1803-13. PubMed ID: 17641047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient CTL productivity of modified fusion cells by increase of heat shock protein 70.
    Koide T; Iinuma H; Fukushima R
    Oncol Rep; 2009 Mar; 21(3):737-46. PubMed ID: 19212634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-derived heat shock protein 70 peptide complexes are cross-presented by human dendritic cells.
    Noessner E; Gastpar R; Milani V; Brandl A; Hutzler PJ; Kuppner MC; Roos M; Kremmer E; Asea A; Calderwood SK; Issels RD
    J Immunol; 2002 Nov; 169(10):5424-32. PubMed ID: 12421917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient induction of a Her2-specific anti-tumor response by dendritic cells pulsed with a Hsp70L1-Her2(341-456) fusion protein.
    Fu Q; Wu Y; Yan F; Wang N; Wang W; Cao X; Wang Y; Wan T
    Cell Mol Immunol; 2011 Sep; 8(5):424-32. PubMed ID: 21785448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric cancer-derived heat shock protein-gp96 peptide complex enhances dendritic cell activation.
    Lu WW; Zhang H; Li YM; Ji F
    World J Gastroenterol; 2017 Jun; 23(24):4390-4398. PubMed ID: 28706421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial heat shock proteins promote CD91-dependent class I MHC cross-presentation of chaperoned peptide to CD8+ T cells by cytosolic mechanisms in dendritic cells versus vacuolar mechanisms in macrophages.
    Tobian AA; Canaday DH; Boom WH; Harding CV
    J Immunol; 2004 May; 172(9):5277-86. PubMed ID: 15100266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and cellular requirements for enhanced antigen cross-presentation to CD8 cytotoxic T lymphocytes.
    Oizumi S; Strbo N; Pahwa S; Deyev V; Podack ER
    J Immunol; 2007 Aug; 179(4):2310-7. PubMed ID: 17675492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heat shock protein 90 targets a chaperoned peptide to the static early endosome for efficient cross-presentation by human dendritic cells.
    Tanaka T; Okuya K; Kutomi G; Takaya A; Kajiwara T; Kanaseki T; Tsukahara T; Hirohashi Y; Torigoe T; Hirata K; Okamoto Y; Sato N; Tamura Y
    Cancer Sci; 2015 Jan; 106(1):18-24. PubMed ID: 25414129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells.
    André F; Chaput N; Schartz NE; Flament C; Aubert N; Bernard J; Lemonnier F; Raposo G; Escudier B; Hsu DH; Tursz T; Amigorena S; Angevin E; Zitvogel L
    J Immunol; 2004 Feb; 172(4):2126-36. PubMed ID: 14764678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined use of dendritic cells enhances specific antileukemia immunity by leukemia cell-derived heat shock protein 70 in a mouse model with minimal residual leukemia cells.
    Iuchi Y; Torimoto Y; Sato K; Tamura Y; Jimbo J; Inamura J; Shindo M; Ikuta K; Ohnishi K; Kohgo Y
    Int J Hematol; 2006 Dec; 84(5):449-58. PubMed ID: 17189229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a novel Hsp70-based DNA vaccine as a multifunctional antigen delivery system.
    Yamaoka A; Guan X; Takemoto S; Nishikawa M; Takakura Y
    J Control Release; 2010 Mar; 142(3):411-5. PubMed ID: 19913062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hsp70-like protein 1 fusion protein enhances induction of carcinoembryonic antigen-specific CD8+ CTL response by dendritic cell vaccine.
    Wu Y; Wan T; Zhou X; Wang B; Yang F; Li N; Chen G; Dai S; Liu S; Zhang M; Cao X
    Cancer Res; 2005 Jun; 65(11):4947-54. PubMed ID: 15930317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent tumor-specific immunity induced by an in vivo heat shock protein-suicide gene-based tumor vaccine.
    Ren W; Strube R; Zhang X; Chen SY; Huang XF
    Cancer Res; 2004 Sep; 64(18):6645-51. PubMed ID: 15374979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat shock proteins 70 and 60 share common receptors which are expressed on human monocyte-derived but not epidermal dendritic cells.
    Lipsker D; Ziylan U; Spehner D; Proamer F; Bausinger H; Jeannin P; Salamero J; Bohbot A; Cazenave JP; Drillien R; Delneste Y; Hanau D; de la Salle H
    Eur J Immunol; 2002 Feb; 32(2):322-32. PubMed ID: 11807771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens.
    Haicheur N; Bismuth E; Bosset S; Adotevi O; Warnier G; Lacabanne V; Regnault A; Desaymard C; Amigorena S; Ricciardi-Castagnoli P; Goud B; Fridman WH; Johannes L; Tartour E
    J Immunol; 2000 Sep; 165(6):3301-8. PubMed ID: 10975847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo and in vitro activation of T cells after administration of Ag-negative heat shock proteins.
    Breloer M; Fleischer B; von Bonin A
    J Immunol; 1999 Mar; 162(6):3141-7. PubMed ID: 10092763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.